David Pyott is chairman and CEO of the global healthcare company Allergan. Headquartered in Irvine, California, Allergan provides speciality pharmaceutical products worldwide, developing and commercialising products in ophthalmology (a market in which it is the fastest growing company in the world), neurosciences, medical dermatology, medical aesthetics and other speciality markets.
David Pyott joined Allergan in January 1998, as president and CEO. In 1998, he refocused the company’s strategy on specialty pharmaceuticals as well as restructuring Allergan’s worldwide operations. Savings from these streamlining programmes were reinvested into a major expansion of R&D and sales forces worldwide. In April 2001, Pyott was appointed chairman of the board of Allergan.
Before joining Allergan, Pyott was the head of the Novartis Nutrition Division and a member of the executive committee of the Switzerland-based company Novartis. He has a Diploma in German and European Law from the Europa Institute at the University of Amsterdam, a Master of Arts degree from the University of Edinburgh, and an MBA from London Business School.
Continue Reading in PDF Format . . .